Company: TVRD
Filing Date: 2025-02-14
Form Type: S-4/A
Source: 0001104659-25-013053
Chunk: 570

Company: Tvardi Therapeutics, Inc.
Filing Date: 2025-02-14
Form: S-4/A
Chunk 570
---
 ​ | ​   
 ​   | ​ 
 ​ | ​ 
 ​ 
 ​ |
|:--------------------------------|:--|:--|:--------------------------------|:--|------:|:--|:--|:--|:-----|:--|:--|:--|:--|:--|:---------|:--|:----|:--|:--|:--|:-------------------------------|:--|------:|:--|:--|:--|:-----|:--|:--|:--|:--|:--|:---------|:--|:----|:--|:--|
| Impairment of long-lived assets | ​ | ​ | ​                               | $ | 4,274 | ​ | ​ | ​ | ​    | $ | — | ​ | ​ | ​ | ​        | ​ | N/A | ​ | ​ | ​ | ​                              | $ | 4,274 | ​ | ​ | ​ | ​    | $ | — | ​ | ​ | ​ | ​        | ​ | N/A | ​ | ​ |

**For the three and nine months ended September 30, 2024, Cara recognized a $4.3 million impairment charge on its right of use asset as a result of the assignment of its corporate lease in September 2024. Inventory Write-Down**

| ​                    
 ​                    
 ​                    | ​ 
 ​ 
 ​ | ​ 
 ​ 
 ​ | Three Months EndedSeptember 30, 
 2024                            
 Dollar amounts in thousands     |   |       |   | ​ | ​ | 2023 |   |   |   | ​ 
 ​ 
 ​ | ​ 
 ​ 
 ​ | ​        
 % change 
 ​        | ​ 
 ​ | ​   
 ​   | ​ 
 ​ | ​ 
 ​ 
 ​ | ​ 
 ​ 
 ​ | Nine Months EndedSeptember 30, 
 2024                           
 Dollar amounts in thousands    |   |       |   | ​ | ​ | 2023 |   |   |   | ​ 
 ​ 
 ​ | ​ 
 ​ 
 ​ | ​        
 % change 
 ​        | ​ 
 ​ | ​   
 ​   | ​ 
 ​ | ​ 
 ​ 
 ​ |
|:---------------------|:--|:--|:--------------------------------|:--|------:|:--|:--|:--|:-----|:--|:--|:--|:--|:--|:---------